Alcoholism is a disease characterised by continuous heavy drinking. Until people with alcohol use disorder admit to problems with alcohol and stop drinking, the risk of alcohol use disorder continues which affects both physical and mental health.
Alcohol starts to injure the brain once it reaches the bloodstream.
Excessive consumption can lead to Alcohol-Related Brain Damage, or ARBD, which is a type of brain disorder caused by alcohol consumption. Brain shrinkage caused by alcohol abuse is permanent, as alcohol kills brain cells and grey matter.
For more information and effects click ‘Learn More’.
Family Recovery Compass is a newsletter for friends and family members who feel trapped between supporting a loved one in addiction, and protecting their own wellbeing.
Every week, we tackle one specific situation in addiction family dynamics, and deliver practical decision-making frameworks and exact dialogue scripts – that help you respond with confidence instead of reaction.
Every month, we bring you an unfiltered recovery conversation with someone who’s either experienced addiction firsthand, or works closely with those in recovery.
No sanitised success stories – just practical insights on what actually works in recovery, that you can apply, in your life too.
Recovery capital is the internal and external resource used to begin the recovery process and maintain sobriety. This combines personal, social, and community support to provide a joined-up approach that supports the addict through recovery.
Do you or a loved one need addiction treatment for alcohol or drugs? Thousands blindly walk into addiction treatment in expensive rehab centres and find that the reality doesn’t meet expectations.
If you’re considering rehab treatment, first check our ultimate guide for complete instructions on how to find the right rehab centre for you.
Take-home Naloxone kits help families and loved ones respond quickly in an opioid overdose emergency, until emergency services arrive. Kits contain nasal or injectable forms of Naloxone.
Changes in legislation mean Naloxone kits are now more widely available from pharmacies and drug services, including Abbeycare.
For additional information, click ‘Learn More’ below.
Overcoming alcohol addiction means first ceasing alcohol intake, and taking care of physical and chemical withdrawal symptoms.
Detoxing from alcohol means undergoing withdrawal from alcohol, but with the assistance of prescribed medication and detox phase, to substitute in place of the alcohol itself.
Alcohol rehab focuses on tackling the problems underneath alcoholism, such as grief, trauma, depression, and emotional difficulties, in order to reduce continuing drinking after treatment.
Inpatient services at an alcohol rehab programme provides 24 hour access to specialist care.
Alcohol home detox provides a means of semi-supervised addiction treatment in the comfort of your home. It’s often suitable for those with inescapable practical commitments, or where a reduced budget for treatment is available.
An at-home detox is the most basic detox option available from Abbeycare, and assumes you have support available, post-detox, for the other important elements of long-term addiction recovery.
The term alcoholism refers to the consumption of alcohol to the extent that the person is unable to manage their own drinking habits or patterns, resulting in side-effects that are detrimental to the quality of life and health of the alcoholic, or those around them.
An alcoholic is someone who continues to compulsively abuse alcohol in this way, despite the negative consequences to their lives and health.
Immediately following treatment, the early stages of recovery and abstinence are most vulnerable to lapses.
At Abbeycare, a structured and peer-reviewed aftercare plan is usually prepared whilst still in treatment. This comprises social, peer, and therapeutic resources individuals draw upon, following a residential treatment programme for drug or alcohol misuse.
Clinically managed residential detoxification is:
– A structured detox that uses medication-assisted treatment and regular physical health observations
– Takes place in an inpatient rehabilitation unit or hospital
– Typically lasts from 7-10 days, but in Abbeycare, it is incorporated into a 28-day rehab programme
Cognitive Behavioural Therapy is a well-known therapy option used by doctors at drug and alcohol treatment facilities for the treatment of substance use disorders.
It is a form of talking therapy that helps one mange their problems by changing how they think and behave. This form of therapy is used to treat depression and anxiety and is useful for physical health problems as well as one’s mental health.
Family Therapy at Abbeycare Scotland or Gloucester is realistic, compassionate, and appropriate for families and loved ones of addicts.
Family therapeutic interventions in residential rehabilitation have been designed to support those living with or caring for participants entering the Abbeycare Programme.
Support for families in a group setting allows for a safe, constructive, and confidential place to listen and share common experiences.
Inpatient rehab is drug and/ or alcohol treatment in a rehab centre, where patients remain on-site for the duration of inpatient rehabilitation.
It includes detoxification from drugs, therapy (group work and 1-2-1 sessions), and aftercare planning. Inpatient rehabs typically last 28 days, but this varies on an individual basis.
Long-term treatment at Abbeycare has been developed for those suffering from alcohol or drug addiction. Completing a long-term drug and alcohol inpatient programme may be the solution to problematic substance use.
Motivational Enhancement Therapy can be used by trained addiction recovery therapists to elicit internal changes within and promote long-term recovery from substance use disorder.
All the answers to addiction can be found within with this comprehensive and successful therapy concept leads to behavioural changes, reflective listening, self-motivational statements, and a comprehensive recovery process.
Outpatient drug or alcohol rehab is daytime treatment as opposed to living in a treatment facility.
Outpatient treatment is similar to inpatient in terms of the methods used to treat substance abuse. Where they differ is in their approach to recovery.
Abbeycare’s prison to rehab is a 12-week structured rehab programme which involves direct transfer from prison. The suitability of the candidate is decided by prison staff.
Short-term residential treatment programmes are the chance to press the reset button and access a therapeutic programme designed to create recovery from the use of alcohol and drugs.
Feeling stuck in a rut. Want to stop but can’t seem to achieve sobriety?
Click below.
The 12-step programme was created by alcoholics anonymous (AA), and is specifically designed to aid addicts in achieving and maintaining abstinence.
The central ethos behind the programme is that participants must admit and surrender to a divine power to live happy lives. Ideas and experiences are shared in meetings, and help is sought in an attempt to achieve abstinence.
Abbeycare’s policy to respect your privacy and comply with any applicable law and regulation regarding any personal information we may collect about you, including across our website and other sites we own and operate.
Consuming Amphetamines over a minimum of 200 days within a 1 year period, according to the DSM-IV criteria [1]
A 25% loss of dopamine transporters in the striatum and a 165% increased risk of developing Parkinson's disease [2] [3]
Rebound hunger and compulsive skin scratching within 24-72 hours of not taking amphetamines
Physical Indicators Of Amphetamine Addiction
Rapid Weight Loss
A 15kg weight loss within 10 days is a physical indicator of amphetamine addiction because [6]:
Noradrenaline levels rise by up to 400% within 45 minutes of drug-taking, increasing resting energy expenditure by over 10% due to the overstimulation of alpha and beta-adrenergic receptors [7] [8]
68.4% experience a reduction in appetite due to the inhibition of hunger signals from the hypothalamus following a 5-fold increase in serotonin within 60 minutes of drug use [8] [9]
Daily calorie intake decreases by 24 - 30% after dopamine increases by up to 700% in the striatum, remaining elevated for up to 12 hours and regulating appetite in 22% of users with binge-eating disorder [7] [10] [11]
One study found that some amphetamine addicts lose 5kg in weight after not eating for 3 – 4 days at a time, although some women report gaining between 15 – 25kg during periods of abstinence [6].
Dental Issues
Meth Mouth is a physical indicator of amphetamine addiction because amphetamines reduce the stimulation of saliva to less than 0.7ml/min (normal range = 1 – 2 ml/min) and decrease the salivary Ph to an average of 5.48 (normal range = 6.2-7.6), leading to [12]:
Tooth decay in 3 or more teeth in 78%, anterior caries in 5 or more teeth surfaces in 18.4%, Periodontitis (severe gum disease) in 21.1%, and painful aching in the mouth whilst eating in 59.5% [13]
Affected sense of taste (e.g. sensitivity to sugar and salt) in 30 - 42% of users consuming methamphetamine orally, via inhalation, or smoking [13]
60% of amphetamine addicts have one or more missing teeth (average = 5 teeth missing), and 13.3% wear dentures because [14]:
Stimulant use reduces blood glucose by 15%, often leading to cravings for sugary substances (e.g. Coca-Cola, sweets) [15]
Chronic amphetamine users (average = 12 years of drug abuse) drink around 35 sugared sodas per month, and 32% drink two or more per day (recommended intake = less than 3 cans per week) [14] [15]
Heavy amphetamine users (>10 times in 30 days) are 45% more likely to avoid certain foods compared to light users (<10 times in 30 days) due to higher rates (10 – 15%) of mouth pain caused by dental problems (e.g. gum disease, abscesses) [13].
Skin Picking
Skin picking is a physical indicator of amphetamine addiction because the extracellular concentrations of dopamine and glutamate in the striatum increase by over 50% within 2 hours of drug use, leading to [16]:
Tactile hallucinations (e.g. “meth mites”) and paranoid delusions in 25% within 1 year of drug abuse; users feel bugs crawling under the skin and repeatedly scratch/pick with the intention of removing the imagined insects [17]
Skin picking caused by amphetamine-induced hallucinations lasts around 2 – 3 hours, although some cases last up to 1 week and may be mistaken for schizophrenia [17]
Skin picking during amphetamine addiction is exacerbated by abscesses in 46% of users who smoke or inject methamphetamine daily for 6 months because:
20% pick at the abscess with fingers due to swelling, pain, redness, and heat at the wound site, taking over 3 weeks to heal in 19% of users [18]
Infections occur as 97% attempt to self-treat the wound (e.g. draining the abscess with a knife or syringe), 11% do not sterilise the area before making an incision, and only 12% seek medical care [18]
Smoking meth increases the risk of developing an abscess by 65% compared to injecting because sores develop around the mouth and nose due to burns from smoking on a pipe, typically starting as red dots or abrasions and developing into larger wounds (e.g. ulcers, pustules) [18].
Accelerated Ageing
Accelerated ageing is a physical sign of amphetamine addiction because:
Some users don’t sleep for 3 - 4 days at a time; >24 hours of prolonged wakefulness increases the brain age by 1 – 2 years, although the effect can be reversed by sleeping 8 hours over a 1-month period [19]
Regular users are 4 times more likely to have reduced skin elasticity, dry wrinkled skin, and sunken eyes due to recurring dehydration (water = less than 7% of total body weight), resulting in 35% being unable to urinate for around 3 hours after drug-taking [4] [20]
A 30 – 50% decline in muscle mass, typically occurring between ages 40 – 80, is accelerated in 27-year-olds struggling with stimulant addiction due to malnourishment after 1 – 2 years of drug-taking and 16% lower BMI values in comparison to non-users [5] [21]
Cortical grey matter declines by 6.4 - 8.5% per decade after consuming stimulant drugs 5 – 6 days per week for 5 - 10 years, compared to 0.1 - 3.5% in non-users, accelerating cognitive decline and increasing the risk of dementia by over 20-fold [22] [23]
Muscle Twitching
Muscle twitching is a physical indicator of amphetamine addiction because amphetamines increase acetylcholine levels by up to 210% in the hippocampus and caudate nucleus [24]:
Muscle twitching typically occurs within 2 to 4 days of amphetamine use, followed by muscular aches, pains, and stiffness in up to 60% [4]
In a case study, a 31-year-old man experienced muscle spasms around 5 times per day after inhaling amphetamines 2 – 3 times daily for 5 consecutive years [25]
Amphetamine abuse increases the risk of developing Parkinson’s disease by 165% due to a 20 – 25% dopaminergic cell loss, resulting in involuntary shaking and twitching of mainly hands, legs, and facial (e.g. chin) muscles [26].
Psychological Indicators Of Amphetamine Addiction
Hyper Fixations On Tasks
Hyper fixations on tasks are a psychological indicator of amphetamine addiction because dopamine levels in the striatum increase by up to 700% and remain elevated for up to 12 hours after use of amphetamines [7].
Peterson et al (2015), found that 20 university students misused amphetamines typically prescribed to treat ADHD or narcolepsy (e.g. dextroamphetamine) to have ‘tunnel vision’ and ‘pull all-nighters', enabling them to study for 12 – 13 hours at a time:
“Sometimes I am really lazy, I don’t want to do my work, but with Adderall you kind of jumpstart your motor, it gets you going, it is a really good remedy, it’s the missing ingredient” - a 32-year-old PhD student
“There is an internal quieting, pushing your mood into a more positive direction, it’s something that allows you to engage in a task and feel good while it is being completed" - a 25-year-old MA Student [27].
Delusions Of Grandeur
Delusions of grandeur are a psychological indicator of amphetamine addiction because disruptions in neurotransmission within the central nervous system lead to:
Grandeur delusions in 17.7% after abusing amphetamines for 10 – 14 years, causing users to believe they are "extremely important" (e.g. a royal figure) after consuming around 1.08g per day [28]
49% of daily amphetamine users report feeling like they had special powers at least once after smoking, injecting, or snorting doses between 0.4 - 0.9g daily [29]
Paranoid Delusions are a psychological indicator of amphetamine addiction because interruptions in neurotransmission within the nigrostriatal and mesolimbic pathways results in:
Persecutory delusions in 31.3% of chronic amphetamine users (daily use for 10+ years), typically lasting 2 – 3 hours with beliefs that an entity, person, or organisation is trying to harm them [28]
Delusions of a jealous or controlling nature in 24.2%; users typically believe a spouse is having an affair whilst having no objective evidence, although this is more common in women than men (50% vs 16%) [28] [29]
In a case study by Grelotti et all (2010), a 37-year-old man developed paranoid delusions 2 years after beginning to smoke methamphetamine daily, lasting 5 months after drug withdrawal with recurring beliefs about a sports car being the FBI following him [31].
Racing Thoughts And Disjointed Speech
Racing thoughts and disjointed speech are psychological indicators of amphetamine dependence because a 400% increase of noradrenaline enhances alertness and arousal within 45 minutes of drug-taking, leading to [7]:
Disorganised thinking and speech in up to 55% of daily amphetamine users, including continual loud outbursts, abrupt switching of topics, and the slurring of words [30]
Users appear alert, agitated, and ‘over-reactive’, with rapid incessant speech and unpredictable behaviour, including talking to themselves or arguing/yelling at others without an explanation [17]
Racing thoughts and disjointed speech caused by amphetamine misuse typically subside within 1 month, although 30% experience symptoms for 1 - 6 months, and 4% of cases develop into Schizophrenia [32].
Who Is Most Likely To Develop An Amphetamine Addiction?
Group More/Less Likely
Why?
Prescribed For ADHD/Narcolepsy
14.3% abuse prescription stimulants (e.g. Ritalin) after taking ADHD medication from age 6; 2.9 times more likely to become addicted due to impulsivity + emotional dysregulation [33] [34]
Up to 47% of narcoleptic patients take prescribed amphetamines, and 13.3% have a previous SUD diagnosis (e.g. 20% for methamphetamine) [35]
Students
14.2% misuse Adderall/Ritalin, and 4% become addicted after initially using to help with concentration/studying (65.2%) or increase alertness (47.5%) [35]
Stimulant abuse before university increases the risk of developing an addiction during university by 3-fold [36]
Athletes/Bodybuilders
13.3% misuse amphetamines alongside anabolic steroids (AS) to minimise fatigue whilst enhancing sport performance and maintaining fitness levels [37]
30% become dependent on AS and are 4.5 times more likely to become dependent on stimulants compared to non-steroid users [38] [39]
Body Dysmorphia Sufferers
6.8% develop a stimulant use disorder vs roughly 2% of the general population [40]
Despite normal BMI values (18.5 - 24.9), some become addicted due to feeling ‘fat’ and claiming the drug makes them lose 15kg in 10 days:
“I was 46 kg. Friends all said I was thin, but I still thought I was fat. I wanted to lose weight.” [6]
Alcoholics/Diazepam Addicts
Alcohol use increases the odds of lifetime amphetamine use by 4.22 times; for every day of binge drinking, the odds of same-day amphetamine use increase by 4.5 times [41]
Up to 50% also become dependent on stimulants to increase/decrease the effects of benzodiazepines, experiment, or relax/relieve tension [42]
Amphetamines Addiction Vs Other Drugs
Amphetamines
LSD
Barbiturates
Potency
Lethal dose in adults = around 20-25 mg/kg
Lethal dose = around 14 milligrams (active from 0.02 mg)
Lethal dose = roughly 2–3 g for amobarbital and pentobarbital
Two patients experienced fatal intracranial hemorrhages [45]
Involved in 29% of fatal poisonings [46]
About the author
Mischa Ezekpo
Mischa Ezekpo has a Bachelors degree in Psychology from Northumbria
University, and a Masters degree in Childhood Development and
Wellbeing, from Manchester Metropolitan University. Since 2018, Mischa
has written and published work on Addiction, Mental Health, Depression, and Eating Disorders. Content reviewed by Laura Morris (Clinical Lead).